Immunotherapy of Gynaecological High-Risk Human Papilloma Virus Infection With Human Leukocyte Ultrafiltrate
Objective: In this preliminary presentation the outcome of women following systemic treatment of cervical human papilloma virus (HPV) with a leukocyte ultrafiltrate is reported.
Saved in:
Main Authors: | H. Spitzbart (Author), U. B. Hoyme (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2000-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus
by: Nianmin Shi, et al.
Published: (2017) -
Particular features of the clinical course of the papilloma viral infection depending on quantitative indices of human papilloma viruses of a high carcinogenic risk
by: M. R. Rakhmatulina, et al.
Published: (2017) -
Human papilloma virus infection and miscarriage: is there an association?
by: Alexandros Basonidis, et al.
Published: (2020) -
CARCINOMA OF THE LARYNX AND HUMAN PAPILLOMA VIRUS INFECTION
by: Georgi N. Nikolov, et al.
Published: (2016) -
Frequency of high-risk genotypes of human papilloma virus in oral lesions.
by: Martha Rebolledo-Cobos, et al.
Published: (2020)